Amoytop Acquires Skyline To Kickstart China 2025 M&A Activity

 
• By Dexter Jie Yan
  
Xiamen Amoytop Biotech has announced the first acquisition between Chinese biopharmas and pre-revenue biotechs in years. (Shutterstock)

More from China

More from Business